AI is increasingly used to accelerate and improve drug discovery and development. AI tools, like AlphaFold and autonomous labs, help identify targets and process massive datasets. Regulatory standards ...
Competition to create new brand-name drugs is a key driver of innovation in the United States. Unfortunately, it also drives the relentless growth of healthcare spending. That’s because development of ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Medicare drug price negotiation would be scaled to cover more drugs faster, eliminate “blockbuster” exemptions, add international reference pricing elements, and extend savings beyond Medicare into ...
Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...
The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for biosimilars, which are generic versions of complex biological drugs. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results